Gina Fragione, MPAS, PA-C presented a lecture on Comorbidities in Rosacea and Acne: Fact or Fiction at the SDPA Annual Summer Conference. She began by discussing the pathophysiology of rosacea as primarily an inflammatory disorder consisting of a dysregulation of innate an adaptive immune system, and that it shares a common general pathophysiology with reported …
Did you know that over 20 comorbidities have been linked to Atopic Dermatitis in 2018? Dr. Robert Sidbury from Seattle Children’s Hospital helped attendees of the SDPA Summer Conference sift through the published data related to atopic comorbidities. Dr. Sidbury relayed that it is an “incredibly dynamic” time in the field of atopy in both …
For the first product theater of the SDPA Annual Summer Conference, Cynthia Trickett, PA-C, reviewed Tremfya. Ms. Trickett specializes in the treatment of patients with psoriatic disease and discussed Tremfya as a first line therapy medication for patients 18 years or older with moderate to severe plaque psoriasis. As Ms. Trickett stated, “psoriasis affects and …
Dr. Rosen began Day 1 of the SDPA Annual Summer Conference this morning with a complementary message thanking PAs for being “the most open to adopting new technology and new drugs and pushing your doctors into the 21st century”. Dr. Rosen also vocalized his continued support of PAs! He started his review of the latest …
The SDPA Annual Summer Conference kicked off the morning pre-conference track with in an-depth look at dermoscopy. Dr. Jennie Clarke provided a quick overview of the history of dermoscopy while emphasizing that dermoscopy is not used for diagnosis but for guidance to determine the need to biopsy suspicious lesions. She highlighted that dermoscopy can be …